GLP-1 Peptide Side Effects & How to Manage Them
Last updated July 2, 2026 · Medically reviewed by David Chen, MD, PhD
The side effects of GLP-1 peptides are mostly gastrointestinal — nausea, vomiting, diarrhea, and constipation — and they cluster during dose escalation, easing once the body adapts at maintenance. Each compound has its own profile; select one below to see the positive and negative effects with the trial or community source for each.
Positive
| Effect | Notes |
|---|---|
| Weight loss | ~28.3% at 12 mg over 80 weeks; up to 30.3% in BMI ≥35 by 104 weeks (TRIUMPH 1, 2026) |
| Reduced appetite | primary driver of weight loss across all dose arms (TRIUMPH 1, 2026) |
| Improved blood sugar | 2.0% HbA1c drop with 16.8% weight loss in type 2 diabetes (TRANSCEND-T2D-1, 2026) |
| Knee osteoarthritis pain relief | WOMAC pain fell ~76% in obesity + knee OA (TRIUMPH 4, 2025) |
| Improved lipids | lower triglycerides and LDL on treatment (Phase 2, 2023) |
| Lower blood pressure | modest drop in systolic blood pressure (Phase 2, 2023) |
| Quieter food noise | users describe far less intrusive background hunger (Community Notes) |
| Improved focus | attention freed from food preoccupation (Community Notes) |
| Reduced cravings | lower alcohol and substance cravings reported anecdotally (Community Notes) |
Negative
| Effect | Notes |
|---|---|
| Nausea | most common, 42.4% at 12 mg vs 14.8% placebo (TRIUMPH 1, 2026) |
| Vomiting | 25.3% at 12 mg vs 4.8% placebo (TRIUMPH 1, 2026) |
| Diarrhea | 32.0% at 12 mg vs 13.5% placebo, usually transient (TRIUMPH 1, 2026) |
| Constipation | 26.1% at 12 mg vs 10.9% placebo (TRIUMPH 1, 2026) |
| Dysesthesia (skin tingling) | distinctive to reta, 7–21% at higher doses (Phase 2, 2023) |
| Heart rate increase | modest, dose-dependent, peaks ~24 weeks then declines (Phase 2, 2023) |
| Injection site reactions | mild redness or irritation (TRIUMPH 1, 2026) |
| Fatigue | occasional tiredness during early weeks (Community Notes) |
| Anhedonia | muted reward or flat affect reported by some users (Community Notes) |
Managing side effects
The single most effective lever is escalation speed: stepping the dose up slowly is what keeps gastrointestinal effects tolerable. Persistent nausea at a given dose is usually a signal to hold there longer rather than push higher. Smaller, more frequent meals and adequate hydration help, and some researchers split a weekly dose into two smaller injections to lower each peak without changing total weekly exposure.
Plan a gradual schedule in the dosing calculator, and make sure doses are measured accurately by reconstituting correctly with the reconstitution calculator.
Metabolic optimization compounds, ready when you are.
- 99%+ purity on every compound
- Batch-matched COAs included
- Discreet, same-day shipping
- Metabolic optimization compounds from $70
- 24/7 research support team
- GLP research compounds
- US-based peptide vendor
- Lab supplies included